Brain tumor MRI: Difference between revisions
Jump to navigation
Jump to search
(→MRI) |
m (Bot: Removing from Primary care) |
||
| (10 intermediate revisions by 5 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{CMG}} | {{CMG}} | ||
{{Brain tumor}} | {{Brain tumor}} | ||
==Overview== | ==Overview== | ||
Imaging plays a central role in the diagnosis of brain tumors. | Imaging plays a central role in the diagnosis of brain tumors. On MRI brain, brain tumor is characterized by hypointense or isointense on T1-weighted scans, or hyperintense on T2-weighted MRI. | ||
==MRI== | ==MRI== | ||
On MRI, they appear either hypo- (darker than brain tissue) or isointense (same intensity as brain tissue) on T1-weighted scans, or hyperintense (brighter than brain tissue) on T2-weighted MRI. Perifocal edema also appears hyperintense on T2-weighted MRI. [[Contrast agent]] uptake, sometimes in characteristic patterns, can be demonstrated on either CT or MRI-scans in most malignant primary and metastatic brain tumors. This is due to the fact that these tumors disrupt the normal functioning of the [[blood-brain barrier]] and lead to an increase in its [[permeability]]. | *On MRI, they appear either '''hypo'''- (darker than brain tissue) or '''isointense''' (same intensity as brain tissue) on T1-weighted scans, or '''hyperintense''' (brighter than brain tissue) on T2-weighted MRI. Perifocal edema also appears hyperintense on T2-weighted MRI. [[Contrast agent]] uptake, sometimes in characteristic patterns, can be demonstrated on either CT or MRI-scans in most malignant primary and metastatic brain tumors. This is due to the fact that these tumors disrupt the normal functioning of the [[blood-brain barrier]] and lead to an increase in its [[permeability]]. | ||
*MRI has superior soft-tissue resolution. MRI can better detect isodense lesions, tumor enhancement, and associated findings such as edema, all phases of hemorrhagic states (except hyperacute), and infarction. High-quality MRI is the diagnostic study of choice in the evaluation of intramedullary and extramedullary spinal cord lesions.<ref>Mehta M, Vogelbaum MA, Chang S, et al.: Neoplasms of the central nervous system. In: DeVita VT Jr, Lawrence TS, Rosenberg SA: Cancer: Principles and Practice of Oncology. 9th ed. Philadelphia, Pa: Lippincott Williams & Wilkins, 2011, pp 1700-49. </ref> | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WH}} | |||
{{WS}} | |||
[[Category:Disease]] | |||
[[Category:Brain]] | |||
[[Category:Neurology]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Neurosurgery]] | |||
Latest revision as of 20:41, 29 July 2020
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
|
Brain tumor Microchapters |
Overview
Imaging plays a central role in the diagnosis of brain tumors. On MRI brain, brain tumor is characterized by hypointense or isointense on T1-weighted scans, or hyperintense on T2-weighted MRI.
MRI
- On MRI, they appear either hypo- (darker than brain tissue) or isointense (same intensity as brain tissue) on T1-weighted scans, or hyperintense (brighter than brain tissue) on T2-weighted MRI. Perifocal edema also appears hyperintense on T2-weighted MRI. Contrast agent uptake, sometimes in characteristic patterns, can be demonstrated on either CT or MRI-scans in most malignant primary and metastatic brain tumors. This is due to the fact that these tumors disrupt the normal functioning of the blood-brain barrier and lead to an increase in its permeability.
- MRI has superior soft-tissue resolution. MRI can better detect isodense lesions, tumor enhancement, and associated findings such as edema, all phases of hemorrhagic states (except hyperacute), and infarction. High-quality MRI is the diagnostic study of choice in the evaluation of intramedullary and extramedullary spinal cord lesions.[1]
References
- ↑ Mehta M, Vogelbaum MA, Chang S, et al.: Neoplasms of the central nervous system. In: DeVita VT Jr, Lawrence TS, Rosenberg SA: Cancer: Principles and Practice of Oncology. 9th ed. Philadelphia, Pa: Lippincott Williams & Wilkins, 2011, pp 1700-49.